Non-Biological Complex Drugs

The Science and the Regulatory Landscape

Nonfiction, Health & Well Being, Medical, Specialties, Pharmacy, Science & Nature, Technology, Engineering, Chemical & Biochemical
Cover of the book Non-Biological Complex Drugs by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319162416
Publisher: Springer International Publishing Publication: June 24, 2015
Imprint: Springer Language: English
Author:
ISBN: 9783319162416
Publisher: Springer International Publishing
Publication: June 24, 2015
Imprint: Springer
Language: English

The rise of bio- and nano-technology in the last decades has led to the emergence of a new and unique type of medicine known as non-biological complex drugs (NBCDs). This book illustrates the challenges associated with NBCD development, as well as the complexity of assessing the effects of manufacturing changes on innovator and follow-on batches of NBCDs. It also touches upon proven marketing authorization requirements for biosimilars that could be effective in evaluating follow-on NBCDs, including a demonstration of control over the manufacturing process and a need for detailed physico-chemical characterization and (pre)clinical tests.

This book is meant to be used for years to come as a standard reference work for the development of NBCDs. Moreover, this book aims to stimulate discussions and further our thinking to ensure that decisions regarding the approval of complex drugs are made with relevant scientific data on the table.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

The rise of bio- and nano-technology in the last decades has led to the emergence of a new and unique type of medicine known as non-biological complex drugs (NBCDs). This book illustrates the challenges associated with NBCD development, as well as the complexity of assessing the effects of manufacturing changes on innovator and follow-on batches of NBCDs. It also touches upon proven marketing authorization requirements for biosimilars that could be effective in evaluating follow-on NBCDs, including a demonstration of control over the manufacturing process and a need for detailed physico-chemical characterization and (pre)clinical tests.

This book is meant to be used for years to come as a standard reference work for the development of NBCDs. Moreover, this book aims to stimulate discussions and further our thinking to ensure that decisions regarding the approval of complex drugs are made with relevant scientific data on the table.

More books from Springer International Publishing

Cover of the book The Seneca Effect by
Cover of the book Quantum Theory, Groups and Representations by
Cover of the book Information Systems in the Big Data Era by
Cover of the book Hadamard States from Light-like Hypersurfaces by
Cover of the book The Informal Economy in Global Perspective by
Cover of the book Acute Care Surgery Handbook by
Cover of the book Thermal Transport in Low Dimensions by
Cover of the book Global Leisure and the Struggle for a Better World by
Cover of the book Relational Autonomy and Family Law by
Cover of the book The Rise of Engineering Science by
Cover of the book Modern Algorithms of Cluster Analysis by
Cover of the book Fisheries, Quota Management and Quota Transfer by
Cover of the book Social Networking and Education by
Cover of the book Topological Interactions in Ring Polymers by
Cover of the book Advances in Applications of Industrial Biomaterials by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy